Related Experiment Video
Updated: Oct 8, 2025

Orthotopic Rat Kidney Transplantation: A Novel and Simplified Surgical Approach
Published on: May 7, 2019
Kidney transplantation in pediatric patients with rheumatologic disorders
1Division of Nephrology and Hypertension, Cincinnati Children's Hospital Medical Center.
Insights
Children with end-stage kidney disease from rheumatologic conditions can undergo kidney transplantation. While recurrence is a risk, outcomes are generally good for most conditions, though lupus patients face worse results.
Area of Science:
- Pediatric Nephrology
- Rheumatology
- Transplantation Immunology
Background:
- Children with end-stage kidney disease (ESKD) from rheumatologic conditions require specialized care.
- Key questions involve timing of kidney transplantation, recurrence risk, and management strategies.
Purpose of the Study:
- To review recent developments and literature on kidney transplantation for pediatric ESKD caused by rheumatologic diseases.
- To address post-transplant recurrence, outcomes, and prevention/treatment for common conditions.
Main Methods:
- Literature review of recent developments and relevant studies.
- Focus on systemic lupus erythematosus, IgA nephropathy, IgA vasculitis, and ANCA-associated vasculitis.
Main Results:
- Children with IgA nephropathy, IgA vasculitis, and ANCA-associated vasculitis show similar graft survival post-transplant despite recurrence risk.
- Systemic lupus erythematosus patients experience worse patient and allograft outcomes post-transplant.
- Disease quiescence before transplantation may reduce recurrence risk, which is linked to poorer allograft survival.
Conclusions:
- Kidney transplantation is viable for pediatric patients with systemic rheumatologic conditions.
- Patients must be counseled on the risks of disease recurrence and its impact on transplant outcomes.
- Limited data exist on preventive strategies and treatment for recurrent disease.
Purpose Of Review:
Providers caring for children with end-stage kidney disease from rheumatologic conditions face questions such as when to proceed with kidney transplantation, how common is disease recurrence posttransplant, how does recurrent disease impact patient and allograft outcomes, and what approaches are available to prevent and treat recurrent disease. We discuss recent developments and relevant literature that address these questions for the most common rheumatologic disorders that lead to end-stage kidney disease in childhood namely, systemic lupus erythematosus, IgA nephropathy, IgA Vasculitis/Henoch Schoenlein Purpura, and Anti-Neutrophil Cytoplasmic Antibody (ANCA)-associated vasculitis.
Recent Findings:
Recent data suggest that children with IgA nephropathy, IgA vasculitis, and ANCA-associated vasculitis have similar patient and allograft survival to other conditions despite the risk of recurrent disease, yet those with lupus have worse posttransplant patient and allograft outcomes. A period of disease quiescence may be prudent prior to transplantation to decrease the risk of recurrence, which is associated with decreased allograft survival. Data on preventive strategies and treatment options are limited.
Summary:
It is recommended that patients with systemic rheumatologic conditions not be excluded from kidney transplantation but that patients be counseled on the risk of potential recurrent disease with its impact on transplant outcomes.
Related Concept Videos
Kidney Transplant I: Introduction
Kidney Transplant II: Surgical Procedure
Kidney Transplant III: Nursing Management
Pharmacokinetics in Pediatric Patients: Drug Excretion
Acute Kidney Injury IV: Diagnostic Studies and Prevention
Chronic Kidney Disease III: Interprofessional Care

